Trop-2-directed antibody-drug conjugate

This page covers all Trop-2-directed antibody-drug conjugate drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 1 pipeline (1)

• DATOPOTAMAB · Oncology
  12.1 Mechanism of Action Datopotamab deruxtecan-dlnk, is a Trop-2-directed antibody-drug conjugate.

Patent intelligence

• trop 2 directed antibody drug conjugate patent landscape — aggregated cliff calendar, attackable patents, originator estates